- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2013-09-11 15:53:03
- Reporting Period:
- Filing Date:
- Filing Date Changed:
- Accepted Time:
- 2013-09-11 16:53:03
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|921503||Blyth Inc||BTH||Pharmaceutical Preparations (2834)||362984916|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|937655||B Robert Goergen||C/o Blyth, Inc. |
1 East Weaver Street
Greenwich CT 06831
|Chairman Of The Board & Ceo||Yes||Yes||Yes||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Remaning Holdings||Nature of Ownership||Explanation|
|Common||1,352,750||Indirect||By Spouse via Ropart Investments LLC|
|Common||1,352,750||Indirect||By Ropart Investments LLC|
- Represents a weighted average purchase price for transactions reported on this date. The range of prices for transactions reported in this line is: $10.42 to $10.63. The reporting person undertakes to provide upon request by the Securites and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- Reporting person disclaims beneficial ownership in shares beneficially owned in Ropart Investment, LLC by reporting person's spouse, who is a member in Ropart Investments, LLC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- The reporting person is a member of Ropart Investments, LLC and has reported all of the securities beneficially owned by Ropart Investments, LLC. The reporting person disclaims beneficial ownership of the shares held by Ropart Investments, LLC except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.